Search for: "Generic Pharmaceutical Services, Inc." Results 581 - 600 of 1,029
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jul 2007, 1:01 am
Horace "Hod" Nalle appears to have been general counsel of the multibillion-dollar animal pharmaceutical company for a decade, according to several sources. [read post]
10 Jun 2012, 9:40 pm by Antoinette Konski
Prometheus, Inc., decision, (see our March 20th post) and is currently under review by the U.S. [read post]
26 Jul 2012, 10:33 am by Ben Cheng
”Certiorari stage documents:Opinion below (3d Cir.)Petition for certiorariBrief of respondents Mutual Pharmaceutical Company, Inc. et al. in oppositionAmicus brief of David B. [read post]
31 Jan 2008, 12:22 am
Documents listed are accessible through subscription to the GalleryWatch.com service. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
12 Nov 2014, 10:15 am
Besides construction the case deals with some practice points on the level of details that is required in statements of case on infringement and general pleading issues. [read post]
3 Mar 2013, 8:42 pm by Madhulika Vishwanathan
 Subsequently, I wrote about the draft policy proposal issued by Department of Pharmaceuticals (DOP) on price negotiation of patented drugs. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
17 Mar 2016, 2:45 am by Dennis Crouch
 We continue to await the views of the solicitor general in Life Tech v. [read post]
7 Oct 2011, 7:56 am by Ed Wallis
The civil suit accused the company, which is 41 percent owned by Goldman Sachs Group Inc. [read post]
3 May 2015, 10:33 pm
The General Court answers this question in Joined Cases T-707/13 and T-709/13, which Valentina reports.* Green around the gills? [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
14 Jan 2021, 12:09 pm by luiza
(antitrust violations, generic drugs, patient-allocation) – One of the largest generic-pharmaceutical manufacturers, Sandoz Inc., admitted that $500 million of its product sales were due to illegal agreements with its own competitors. [read post]
8 Jun 2020, 2:02 am by Matrix Legal Support Service
Lehtimaki & Ors v Cooper, heard 14- 15 January 2020 Sainsbury’s Supermarkets Ltd v Visa Europe Services LLP & Ors, heard 20-23 January 2020 R V C, heard 27 January 2020 Peninsula Securities Ltd v Dunnes Stores (Bangor) Ltd (Northern Ireland), heard 28- 29 January 2020 Regeneron Pharmaceuticals Inc v Kymab Ltd, heard 11-12 February 2020 Royal Mencap Society v Tomlinson-Blake, heard 12- 13 February 2020 Shannon v Rampersad & Anor (T/A Clifton… [read post]